Clinical Trials Browser

Phase 2/3 × Unknown × Dasatinib × Clear all

NCT03564470 2022-07-01

Precision Diagnosis Directing HDACi and TKI Target Therapy for Adult Ph-like ALL

Phase 2/3 Unknown

LymphoidOther hematologic neoplasm

Leukemia, Leukemia, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma